How hydrocortisone substitution influences the quality of life and the bone metabolism of patients with secondary hypocortisolism

European Journal of Clinical Investigation, Supplement

Volumn 30, Issue 3, 2000, Pages 55-57

  Wichers, Maria ^a   Springer, W ^a   Bidlingmaier, F ^a   Klingmuller D ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Bone metabolism; Hydrocortisone substitution; Hypocortisolism; Well being

Indexed keywords

HYDROCORTISONE; OSTEOCALCIN;

ADULT; BONE ATROPHY; BONE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOCORTISOLISM; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; WELLBEING;

EID: 0034480761     PISSN: 0960135X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.0300s3055.x     Document Type: Conference Paper

References (15)

1. Reference standards for cortisol production and 17-hydroxy-corticosteroid excretion during growth: Variation in the pattern of excretion of radiolabeled cortisol metabolites
2. The miscible pool and turnover rate of hydrocortisone in man
3. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
4. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis
5. Adrenocortical insufficiency
6. Adrenal insufficiency
7. Klinische selbstbeurteilungsskalen (Ksb-S) aus dem Münchner Psychiatrischen Informations-System (PSY-CHIS München)
8. Klinische selbstbeurteilungsskalen (Ksb-S) aus dem Münchner Psychiatrischen Informations-System (PSYCHIS München)
9. The influence of hydrocortisone substitution on the quality of life and parameter of bone metabolism in patients with secondary hypocortisolism
10. Urinary free cortisol in the assessment of hydrocortisone replacement therapy
11. Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis
12. Molecular basis and clinical applications of biological markers of bone turnover
13. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease
14. Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency